Search filters

List of works by Douglas McNeel

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

A negative selection methodology using a microfluidic platform for the isolation and enumeration of circulating tumor cells ⬇️

scientific article published on June 24, 2013

A phase 1/1b study of satraplatin (JM-216) in combination with docetaxel in patients with advanced solid tumors and metastatic castrate-resistant prostate cancer ⬇️

scientific article published on April 11, 2011

Androgen deprivation as a tumour-immunomodulating treatment

scientific article published on 30 April 2020

Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages

scientific article published on 01 December 2020

Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence

scientific article published on November 2012

Antigen-specific IgG elicited in subjects with prostate cancer treated with flt3 ligand.

scientific article published in May 2005

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells ⬇️

scientific article published on February 25, 2011

Cellular immunotherapies for prostate cancer.

scientific article published on 26 January 2007

Clinical translation of peptide-based vaccine trials: the HER-2/neu model

scientific article published on January 1, 2001

Current controversies in the management of biochemical failure in prostate cancer

scientific article published on November 1, 2012

DNA Vaccines for Prostate Cancer

scientific article

Expression and Immunotherapeutic Targeting of the SSX Family of Cancer–Testis Antigens in Prostate Cancer ⬇️

scientific article published on August 31, 2011

His-tag ELISA for the detection of humoral tumor-specific immunity

scientific article

Human Prostate Tumor Antigen–Specific CD8+ Regulatory T Cells Are Inhibited by CTLA-4 or IL-35 Blockade ⬇️

scientific article published on November 14, 2012

Identification of prostatic acid phosphatase (PAP) specific HLA‐DR1‐restricted t‐cell epitopes ⬇️

scientific article published on August 30, 2011

IgG Responses to Tissue‐Associated Antigens as Biomarkers of Immunological Treatment Efficacy ⬇️

scientific article published on December 19, 2010

Immune-based therapies for prostate cancer.

scientific article

Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response.

scientific article

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

scientific article published on 01 April 2020

Lenalidomide modulates IL‐8 and anti‐prostate antibody levels in men with biochemically recurrent prostate cancer ⬇️

scientific article published on July 11, 2011

MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis

scientific article published on 01 October 2007

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials ⬇️

scientific article published on 06 May 2013

Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice

scientific article published on 14 July 2021

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer ⬇️

scientific article published on December 31, 2011

Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant

scientific article published on 01 January 2003

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma ⬇️

scientific article published on June 7, 2011

Prioritization of cancer antigens: keeping the target in sight

scientific article published on 01 December 2009

Prostate cancer immunotherapy

scientific article published on 01 May 2007

Sipuleucel-T: immunotherapy for advanced prostate cancer.

scientific article published on 03 May 2011

T cells localized to the androgen-deprived prostate are TH1 and TH17 biased.

scientific article published on 27 December 2011

Terminal region recognition factor 1, a DNA-binding protein recognizing the inverted terminal repeats of the pGKl linear DNA plasmids ⬇️

scientific article published on December 15, 1991

The SSX family of cancer-testis antigens as target proteins for tumor therapy ⬇️

scientific article published on October 11, 2010

The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer ⬇️

scientific article published on October 30, 2012

Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

scientific article published on 30 September 2020

Vaccination using peptides spanning the SYT–SSX tumor-specific translocation ⬇️

scientific article published on December 1, 2012

Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells.

scientific article

Paulina is supported by:

About Paulina

Help